MyomoMYO -4.63%55 Gross Margin % is 68.25% as of Mar. 2026, which is 0% above its 10-year median of 68.06. GuruFocus rates MYO with a GF Score™ of 55/100 and a GF Value™ of $3.12 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Myomo ranks better than 72.8% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Myomo's Gross Profit for the
three
months ended in Mar. 2026 was $6.90 Mil. Myomo's Revenue for the
three
months ended in Mar. 2026 was $10.11 Mil. Therefore, Myomo's Gross Margin % for the quarter that ended in Mar. 2026 was 68.25%.
The historical rank and industry rank for Myomo's Gross Margin % or its related term are showing as below:
MYO'
s Gross Margin % Range Over the Past 10 Years
Min: 62.98 Med: 68.06 Max: 74.43
Current: 65.96
During the past 10 years, the highestGross Margin % of Myomo was 74.43%. The lowest was 62.98%. And the median was 68.06%.
MYO's Gross Margin % is ranked better than 72.8% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs MYO: 65.96
Myomo had a gross margin of 68.25% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Myomo was -0.30% per year.
Myomo (AMEX:MYO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Myomo had a gross margin of 68.25% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Myomo Gross Margin % Related Terms
Myomo Gross Margin % Historical Data
* Premium members only.
The historical data trend for Myomo's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MYO vs NSYS, NSPR, TELA: Gross Margin % Comparison
For the Medical Devices subindustry, Myomo's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myomo Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Myomo's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Myomo's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Myomo (MYO) has a Gross Margin % of 68.25% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Myomo and its competitors. This is near median its historical median of 68.06. Over the past decade, Myomo's Gross Margin % has ranged from 62.98 to 74.43. According to the industry distribution chart, Myomo ranks #219 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 27.2%.
Is Myomo's Gross Margin % too high?
Myomo's current Gross Margin % of 68.25% is near median its 10-year median of 68.06. Over the past 10 years, this metric has ranged from a low of 62.98 to a high of 74.43. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Myomo's value of 68.25% is 31.1% above this industry median. Based on the distribution chart, Myomo ranks #219 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Myomo has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Myomo's Gross Margin % compare to NSYS and NSPR?
According to the Medical Devices & Instruments industry distribution chart, Myomo ranks #219 out of 805 companies for Gross Margin %. This puts Myomo in the upper half of its industry. The industry median Gross Margin % is 52.07. Myomo's value of 68.25% is 31.1% above this benchmark. Historically, Myomo's own Gross Margin % has ranged from 62.98 to 74.43 over the past decade. While the company's 10-year median is 68.06 vs. the industry median of 52.07, Myomo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Myomo's current Gross Margin % of 68.25% is 31.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Myomo and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Myomo's current Gross Margin % is 68.25%, which is near median its own 10-year median of 68.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Myomo stock overvalued right now?
Based on GuruFocus' analysis, Myomo (MYO) is currently considered Possible Value Trap. The stock's GF Value™ is $3.12, compared to a current price of $1.03 — trading 67% below its estimated fair value. The current Gross Margin % is 68.25%, which is near median its 10-year median of 68.06 and 31.1% above the Medical Devices & Instruments industry median of 52.07. Myomo's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Myomo (MYO), the current Gross Margin % is 68.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Myomo (MYO) Overvalued in 2026?
Based on GuruFocus' analysis, Myomo stock appears to be undervalued.
The current stock price of $1.03 is trading 67% below its estimated GF Value™ of $3.12.
GuruFocus considers Myomo to be Possible Value Trap.
Key valuation signals for MYO:
Gross Margin %: 68.25% (near median its 10-year median of 68.06)
GF Value™: $3.12 vs. price of $1.03 (67% below fair value)
Industry Position: 31.1% above the Medical Devices & Instruments median (#219 of 805)
No single metric tells the full story. See the MYO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
55GF Score
Get the complete analysis for MYO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MYO has been successfully added to your 
